Study protocol of the GLOW study: maximising treatment options for recurrent glioblastoma patients by whole genome sequencing-based diagnostics-a prospective multicenter cohort study.

Mark P van OpijnenMarike L D BroekmanFilip Yves Francine De VosEdwin CuppenJacobus J M van der HoevenMyra E van LindeAnnette CompterLaurens V BeerepootMartin J van den BentMaaike J VosHelle-Brit FiebrichJohan A F KoekkoekAnn HoebenKuan H KhoChantal M L DriessenHanne-Rinck JeltemaPierre A J T RobeSybren L N Maas

Published in: BMC medical genomics (2022)

ClinicalTrials.gov Identifier: NCT05186064.

Keyphrases

study protocol
end stage renal disease
randomized controlled trial

ejection fraction
newly diagnosed
chronic kidney disease

clinical trial
cross sectional
open label

double blind
placebo controlled